Zobrazeno 1 - 10
of 38
pro vyhledávání: ''
Autor:
Ryul Kim, Sung Soo Yoon, Keonyong Lee, Nam Hoon Kwon, Yoosik Kim, Sunghoon Kim, Youngil Koh, Namseok Lee, Min A. Kim, Daeyoon Kim, Seulki Song, Dongchan Kim, Jayoung Ku
Publikováno v:
Communications Biology, Vol 3, Iss 1, Pp 1-13 (2020)
Communications Biology
Communications biology, vol 3, iss 1
Communications Biology
Communications biology, vol 3, iss 1
Aminoacyl-tRNA synthetase-interacting multifunctional protein 2 (AIMP2) is a non-enzymatic component required for the multi-tRNA synthetase complex. While exon 2 skipping alternatively spliced variant of AIMP2 (AIMP2-DX2) compromises AIMP2 activity a
Autor:
Feng Wang, Naveen Pemmaraju, Li Zhao, Maliha Khan, Tianyu Cai, Hannah C. Beird, Marina Konopleva, Mansour Alfayez, P. Andrew Futreal, Joseph D. Khoury
Publikováno v:
Blood Cancer Journal, Vol 9, Iss 12, Pp 1-9 (2019)
Blood Cancer Journal
Blood Cancer Journal
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, male-predominant hematologic malignancy with poor outcomes and with just one recently approved agent (tagraxofusp). It is characterized by the abnormal proliferation of precursor plasmac
Autor:
Silke Heidenreich, Uwe Platzbecker, Marie Robin, Dietger Niederwieser, Dietrich W. Beelen, Arnon Nagler, Arnold Ganser, Johan Maertens, Arne Brecht, Nicolaus Kröger, Per Ljungman, Johannes Schetelig, Gérard Socié, Matthias Stelljes, Linda Koster, Antonin Vitek, Michel van Gelder, Liesbeth C. de Wreede, Jürgen Finke, Ghulam J. Mufti, Liisa Volin, Guido Kobbe, Ibrahim Yakoub-Agha, Thomas Luft
Publikováno v:
Leukemia, 33(3), 686-695. Nature Publishing Group
Leukemia
Leukemia, 33(3), 686-695
Leukemia
Leukemia, 33(3), 686-695
The causes and rates of late patient-mortality following alloHCT for myelodysplastic syndromes or secondary acute myeloid leukemia were studied, to assess the contribution of relapse-related, treatment-related, and population factors. Data from EBMT
Autor:
Lourdes Cordón, Teresa Bernal, David Martínez-Cuadrón, Raimundo García-Boyero, Jaime Pérez-Oteyza, Joaquin Martinez-Lopez, Mercedes Colorado, Olga Pérez, Fabián Tarín, Alberto Orfao, Sofia Grille, Juan José Garcés, Pau Montesinos, Maria-Teresa Cedena, Marcos González-Díaz, Manuel Pérez-Encinas, Carmen Botella, Miguel-Angel Sanz, Lisette Costilla-Barriga, Joaquín Sánchez, Teresa Caballero-Velázquez, Catia Patricia Simoes, María-Belén Vidriales, Juan-Manuel Alonso-Domínguez, José Antonio Pérez-Simón, María-José Sayas, Celina Benavente, Manuel Barrios, Bruno Paiva, Carlos Rodríguez-Medina, Amparo Sempere, María-Luz Amigo, Claudia Sossa, Jesús F. San Miguel, Josefina Serrano, Enrique Colado, Lorenzo Algarra
Publikováno v:
LEUKEMIA
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Digital.CSIC. Repositorio Institucional del CSIC
Leukemia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Digital.CSIC. Repositorio Institucional del CSIC
Leukemia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
The role of decentralized assessment of measurable residual disease (MRD) for risk stratification in acute myeloid leukemia (AML) remains largely unknown, and so it does which methodological aspects are critical to empower the evaluation of MRD with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce10c3714947a72d5ba288760880620
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8920
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8920
Autor:
Anna Maria Nardozza, Luca Battistini, Mariadomenica Divona, Valentina Alfonso, Emiliano Fabiani, Adriano Venditti, Fabio Forghieri, Eva Barragán, Gisella Guerrera, Serena Travaglini, Maria Ilaria Del Principe, Marco De Bardi, Francesco Lo-Coco, Benedetta Neri, Sabrina Dominici, William Arcese, Daniela F. Angelini, Giovangiacinto Paterno, Maria Irno Consalvo, Maria Teresa Voso, Tiziana Ottone, Serena Lavorgna, Valentina Fiori, Francesco Marchesi, Raffaella Cerretti
Publikováno v:
Blood Cancer Journal, Vol 10, Iss 8, Pp 1-11 (2020)
Blood Cancer Journal
Blood Cancer Journal
Acute myeloid leukemia (AML) with FLT3-ITD mutations (FLT3-ITDmut) remains a therapeutic challenge, with a still high relapse rate, despite targeted treatment with tyrosine kinase inhibitors. In this disease, the CD34/CD123/CD25/CD99+ leukemic precur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6888f7013dd3c0af7faba47ae0c6b24d
http://hdl.handle.net/2108/254167
http://hdl.handle.net/2108/254167
Autor:
Vanderson Rocha, Myriam Labopin, Seiko Kato, Mohamad Mohty, Maria Teresa Van Lint, Guillermo Sanz, Yoshiko Atsuta, Eliane Gluckman, Heiwa Kanamori, Karina Tozatto-Maio, Shinichi Kako, Takahiro Fukuda, Naoyuki Uchida, Yuju Ohno, Annalisa Ruggeri, Satoshi Takahashi, Edouard Forcade, Shinichiro Okamoto, Jorge Sierra, Minoko Takanashi, Riccardo Saccardi, Junya Kanda, Fumihiko Kimura, Tatsuo Ichinohe, Hiromi Hayashi, Fernanda Volt, Shingo Yano, Arnon Nagler
Publikováno v:
Leukemia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Large differences in patient and transplant backgrounds make it difficult to identify consistent prognostic factors of unrelated cord blood transplantation (UCBT) among different populations. Thus, we performed a collaborative study between Eurocord/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84dae6430875d697e34f888913af1e20
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11057
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11057
Autor:
Andrey Zaritskey, Jean Louis Merot, Ekaterina Gresko, Stephan Stilgenbauer, Francesc Bosch, Mehmet Turgut, Kerstin Trunzer, Veronique Leblond, Agostino Cortelezzi, Eugen Tausch, Sebastian Böttcher, Mourad Tiab, Susan Robson, Wolfgang Knauf, Robin Foà, Guy Cantin
Publikováno v:
Scientia
Leukemia
Leukemia, 2020, 34 (2), pp.441-450. ⟨10.1038/s41375-019-0554-1⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2020, 34 (2), pp.441-450. ⟨10.1038/s41375-019-0554-1⟩
Leukemia
Leukemia, 2020, 34 (2), pp.441-450. ⟨10.1038/s41375-019-0554-1⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2020, 34 (2), pp.441-450. ⟨10.1038/s41375-019-0554-1⟩
Bosch, Francesc/0000-0001-9241-2886 WOS: 000523481800012 PubMed: 31455851 GREEN (NCT01905943) is a nonrandomized, open-label, single-arm, phase 3b study investigating the safety and efficacy of obinutuzumab alone or in combination with chemotherapy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a05b94658b0586cb67c72176fa67d0eb
https://hdl.handle.net/20.500.12712/10227
https://hdl.handle.net/20.500.12712/10227
Autor:
Hsin-An Hou, Shang-Ju Wu, Shang-Yi Huang, Feng-Ming Tien, Xiu-Wen Liao, Ming Yao, Yuan-Yeh Kuo, Cheng-Hong Tsai, Chia-Wen Liu, Mei-Hsuan Tseng, Yu-Chiao Chiu, Wen-Chien Chou, Chien-Ting Lin, Hwei-Fang Tien, Chien-Yuan Chen, Ming-Chih Liu, Yen-Ling Peng, Liang-In Lin, Szu-Chun Hsu, Bor-Sheng Ko, Jih-Luh Tang
Publikováno v:
Blood Cancer Journal, Vol 8, Iss 9, Pp 1-13 (2018)
Blood Cancer Journal
Blood Cancer Journal
Mutations of the GATA binding protein 2 (GATA2) gene in myeloid malignancies usually cluster in the zinc finger 1 (ZF1) and the ZF2 domains. Mutations in different locations of GATA2 may have distinct impact on clinico-biological features and outcome
Autor:
Katherine P. Hoversten, Terra L. Lasho, Christy Finke, Ayalew Tefferi, Rhett P. Ketterling, Rangit Vallapureddy, Mrinal M. Patnaik, Naseema Gangat, Curtis A. Hanson
Publikováno v:
Blood Cancer Journal, Vol 8, Iss 1, Pp 1-5 (2018)
Blood Cancer Journal
Blood Cancer Journal
Autor:
Zita Borbényi, Suddhasatta Acharyya, Karen W.L. Yee, Je-Hwan Lee, Massimo Breccia, S. Ide, Árpád Illés, Alan Macwhannell, Carlos Graux, Miklos Egyed, Nancy Zhu, David Valcárcel, James D. Cavenagh, Reinhard Stauder, Huda Salman, Daniel J. DeAngelo, Mikkael A. Sekeres, M. Marker, Oliver G. Ottmann, G. Garcia-Manero, Lucien Gazi, Pierre Fenaux
Publikováno v:
Leukemia
Treatment with azacitidine (AZA), a demethylating agent, prolonged overall survival (OS) vs conventional care in patients with higher-risk myelodysplastic syndromes (MDS). As median survival with monotherapy is